Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New PET scan aims to better detect pancreatic cancer

NCT ID NCT05262855

First seen Nov 01, 2025 · Last updated Jun 12, 2026 · Updated 37 times

Summary

This study tested a special PET scan called [68Ga]FAPI-46 to see how well it finds pancreatic cancer cells in 63 people with early-stage, treatable pancreatic cancer. Participants had the scan before surgery, and results were compared to the actual tumor tissue removed during surgery. The goal was to see if this scan could improve detection and help guide treatment decisions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PDAC - PANCREATIC DUCTAL ADENOCARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • BAMF Health

    Grand Rapids, Michigan, 49503, United States

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

  • NYU Langone Health

    New York, New York, 10016, United States

  • University of California Los Angeles (UCLA) Health

    Los Angeles, California, 90095, United States

Conditions

The condition(s) this trial relates to.

classic familial adenomatous polyposis pancreatic ductal adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.